Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2019OncoTargets and TherapyOpen Access

Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

SDShu DengJohn Innes CentreSLShenyun LinZhejiang Chinese Medical UniversityJSJianping ShenNanjing University of Chinese Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Deng et al. (2019) studied this question.

synapsesocial.com/papers/6a224cd5d0d1b96d67ab53d2https://doi.org/10.2147/ott.s189825
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Non-Hodgkin’s Lymphomas, Version 4.20142014 · 170 citations
  2. 2Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study2011 · 607 citations
  3. 3Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma2001 · 29 citations
  4. 4Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL2004 · 722 citations